Daiwa Securities Group Inc. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,000
+100.0%
1020.0%0.00%
Q2 2022$1,0000.0%1020.0%0.00%
Q1 2022$1,0000.0%1020.0%0.00%
Q4 2021$1,0000.0%1020.0%0.00%
Q3 2021$1,000
-50.0%
1020.0%0.00%
Q2 2021$2,0000.0%1020.0%0.00%
Q1 2021$2,000
+100.0%
1020.0%0.00%
Q4 2020$1,000
-66.7%
102
-60.9%
0.00%
Q3 2020$3,000
-25.0%
2610.0%0.00%
Q2 2020$4,0000.0%2610.0%0.00%
Q1 2020$4,000
-33.3%
2610.0%0.00%
Q4 2019$6,0000.0%261
-9.7%
0.00%
Q3 2019$6,000
-33.3%
2890.0%0.00%
Q2 2019$9,000
-35.7%
2890.0%0.00%
Q1 2019$14,000
+100.0%
289
+42.4%
0.00%
Q4 2018$7,000
-41.7%
2030.0%0.00%
Q3 2018$12,000
-14.3%
2030.0%0.00%
Q2 2018$14,000
+27.3%
2030.0%0.00%
Q1 2018$11,0002030.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders